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Enhancement of mesenchymal 
stem cell chondrogenesis with 
short-term low intensity pulsed 
electromagnetic fields
Dinesh Parate1, Alfredo Franco-Obregón2,3, Jürg Fröhlich  2,4, Christian Beyer4,  
Azlina A. Abbas5, Tunku Kamarul5, James H. P. Hui1,6 & Zheng Yang1,6
Pulse electromagnetic fields (PEMFs) have been shown to recruit calcium-signaling cascades common 
to chondrogenesis. Here we document the effects of specified PEMF parameters over mesenchymal 
stem cells (MSC) chondrogenic differentiation. MSCs undergoing chondrogenesis are preferentially 
responsive to an electromagnetic efficacy window defined by field amplitude, duration and frequency 
of exposure. Contrary to conventional practice of administering prolonged and repetitive exposures 
to PEMFs, optimal chondrogenic outcome is achieved in response to brief (10 minutes), low intensity 
(2 mT) exposure to 6 ms bursts of magnetic pulses, at 15 Hz, administered only once at the onset of 
chondrogenic induction. By contrast, repeated exposures diminished chondrogenic outcome and could 
be attributed to calcium entry after the initial induction. Transient receptor potential (TRP) channels 
appear to mediate these aspects of PEMF stimulation, serving as a conduit for extracellular calcium. 
Preventing calcium entry during the repeated PEMF exposure with the co-administration of EGTA or 
TRP channel antagonists precluded the inhibition of differentiation. This study highlights the intricacies 
of calcium homeostasis during early chondrogenesis and the constraints that are placed on PEMF-based 
therapeutic strategies aimed at promoting MSC chondrogenesis. The demonstrated efficacy of our 
optimized PEMF regimens has clear clinical implications for future regenerative strategies for cartilage.
Articular cartilage is an avascular tissue with low potential for self-repair. When left untreated, lesions of the 
articular cartilage can lead to osteoarthritis1–3. The success of any technology aimed at repairing chondral defects 
will thus be based on its ability to produce tissues that most closely recapitulate the mechanical and biochemical 
properties of native cartilage. To this end many technologies have been advanced yet, none are without draw-
backs. The ‘microfracture’ technique is commonly plagued by the formation of fibro-cartilaginous tissue of low 
dexterity4. Autologous chondrocytes implantation and osteochondral autograft transplantation are limited by 
scarce cartilage production, low proliferative capacity of chondrocytes, chondrocyte de-differentiation and com-
plications due to donor site morbidity5. Stem cell-based approaches are also being actively pursued in hopes of 
improved outcome. Mesenchymal stem cells (MSCs) support chondrogenic differentiation and are an attractive 
cell source for cartilage tissue engineering. However, the neocartilage formed by conventional MSC-based repair 
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methodologies commonly contain a mixture of fibro- and hyaline cartilage6–8 that do not achieve the biochemical, 
mechanical or functional properties of native cartilage.
MSCs can be differentiated along different cell lineages of mesodermal origin including osteoblasts, chondro-
cytes, skeletal myocytes or visceral stromal cells9. Chondrogenic induction of MSCs entails proliferation, conden-
sation, differentiation and maturation10, necessitating endogenous transcriptional and developmental regulators, 
cell-cell and cell-matrix interactions that, in turn, are modulated by environmental stimuli including mechanical 
forces, temperature and oxygen levels10–13. A common objective is to recreate as closely as possible the in vivo 
environmental conditions in vitro so that the rate and quality of chondrogenic development is enhanced and 
the functionality of the repaired tissue improved. To this end, various environmental stimuli such as hypoxia, 
mechanical, electric and electromagnetic stimulation are currently being explored14–16.
Mechanical stimulation can be applied in a semi-controlled manner with the use of bioreactors designed to 
impart shear, compression, tension, or pressure on developing tissues. Appropriately applied mechanical stim-
ulation positively influences MSC-induced chondrogenic differentiation, ECM deposition and the mechanical 
properties of the generated cartilage17–20. At the cellular level the transduction of mechanical signals (mech-
anotransduction) involves their conversion into biochemical responses, often with the assistance of mech-
anosensitive calcium channels21–24. Electromagnetic field (EMF)-stimulation has been shown to promote cell 
differentiation via the modulation of extracellular calcium entry via plasma membrane-embedded cation chan-
nels25–27, raising the intriguing possibility that EMFs may be recruiting related pathways.
Studies examining time-variant or pulsing electromagnetic fields (PEMFs) have alluded to a benefit over 
articular chondrocytes or cartilaginous tissue in vitro, particularly with reference to chondrocyte proliferation, 
extracellular matrix (ECM) deposition, secretory activity and inflammatory status28–35. Studies have also exam-
ined the effects of PEMF-treatment over the chondrogenic differentiation of stem cells derived from bone mar-
row36–38, adipose35, umbilical cord Wharton jelly39, synovial fluid40 or peripheral blood sources40. The reported 
consequences of PEMF-stimulation over chondrogenesis, however, are largely inconsistent. Some studies report 
modest enhancements in the gene expression of Sox9, aggrecan, type II collagen (Col 2) as well as deposition 
of sulfated glycosaminoglycan (sGAG), typically on the order of 2-folds35, 36, whereas other studies show little 
to no effect38–41. On the extreme end of the spectrum, Wang et al.37 reported inhibition of both Sox9 and Col 2 
expression concomitant with induction of hypertrophy and mineralization in response to exposures of 3 h per 
day at an amplitude of 1 mT. Obvious differences in stimulation protocols likely underlie reported discrepancies. 
Existing EMF studies have typically employed exposure durations between 30 minutes to 8 h per day and more 
consistently in the low milli Tesla amplitude range (3–5 mT). Empirical determination of the appropriate expo-
sure and signal parameters for a specific biological response and given tissue are essential as there are indications 
that cell responses to magnetic fields obey an electromagnetic efficacy window defined by a specific combination 
of frequency, amplitude and time of exposure that gives rise to optimum cell response42, 43. Here, we systemat-
ically characterized the effects of PEMF exposure over MSC chondrogenic differentiation by varying the field 
amplitude, exposure duration and dosage with an emphasis on determining the briefest and lowest amplitude 
electromagnetic exposure to render a developmental outcome. Given that both mechanical stimuli and calcium 
entry21, 22 influences chondrogenic differentiation, we investigated the ability of PEMF exposure to influence cal-
cium homeostasis during early induction of MSCs into the chondrogenic lineage, in particular that attributed to 
the Transient Receptor Potential (TRP) family of cation-permeable channels, which has been broadly implicated 
in cellular mechanotransduction23, 44. We show that brief and single exposures to low amplitude PEMFs were 
most effective at stimulating MSC chondrogenesis. Our results also implicate the involvement of calcium influx 
and the mechanosensitive TRP channels, TRPC1 and TRPV4, in the chondrogenic development stimulated by 
targeted PEMF exposure.
Results
Effect of PEMF intensities and exposure durations on MSC chondrogenesis. We first sought to 
determine the magnetic field amplitude and duration of exposure at which MSCs undergoing chondrogenic 
induction are most responsive using starting conditions preliminarily tested in MSCs for chondrogenic regen-
eration39. MSC pellets in chondrogenic differentiation medium were subjected to single exposures to PEMFs 
of 10 min duration at intensities ranging in amplitudes between 0–4 mT (Fig. 1A), then subjected to exposure 
durations between 5 and 60 min at 2 mT intensity (Fig. 1B), applied on the first day of chondrogenic induction. 
RNA analysis monitoring MSC chondrogenic progression at 7 days post-induction showed greatest increases in 
response to 10 min exposures applied at an amplitude of 2 mT as evidenced by enhancements in Sox9, aggrecan 
and Col 2 mRNA expression. By contrast, lower (1 mT) or higher (>3 mT) amplitude of PEMFs (Fig. 1A), or 
briefer (5 min) or longer (>20 min) durations of exposure (Fig. 1B), resulted in overall smaller effect sizes. The 
same EMF efficacy window translated to the expression of cartilaginous ECM macromolecular proteins (Fig. 1C). 
In response to 2 mT amplitude pulsing, a 3-fold increase in Col 2 protein was detected 21 days after chondrogenic 
induction, whereas no increase was detected with exposure to 3 mT. Moreover, a 2-fold increase in sGAG was 
detected in response to exposure to 2 mT PEMFs, whereas 3 mT PEMFs produced a significantly smaller increase. 
The relative ineffectiveness of prolonged exposure to PEMFs was also corroborated at the protein level. Sixty min 
exposures to 2 mT PEMFs did not elicit significant increases in Col 2 formation than 10 min exposures (Fig. 1C). 
With reference to sGAG production, PEMF amplitudes greater than 2 mT, or exposure durations of one hour, 
produced inferior results to 10 min exposures at 2 mT.
Dosage effects of PEMFs over MSC chondrogenesis. We next investigated the effect of repetitive 
exposures to PEMFs. MSCs were exposed to PEMFs at 2 mT for 10 min/day once, twice or thrice on days 1, 2 
and 4 following chondrogenic induction (Fig. 2A). RNA analysis after 7 days of differentiation showed that a 
single exposure produced the greatest and most consistent increase in the expression of chondrogenic markers 
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(Fig. 2A). In another series of experiments, MSCs pellets were exposed once on the first day of chondrogenic 
induction, or weekly for 3 consecutive weeks (Fig. 2B). RNA analysis after 21 days of chondrogenic differentia-
tion showed that a single exposure to 2 mT PEMFs for 10 min given on day 1 of induction gave the greatest and 
most consistent increase in expression of chondrogenic markers relative to no exposure (0 mT) (Fig. 2B). Three 
weekly exposures either rendered no additional benefit (Col 2) or gave similar results to control (0 mT) (Sox9 and 
aggrecan). Moreover, the amount of ECM produced was inversely related to the total number of exposures. Single 
exposures produced >2-folds and ~1-fold increases in Col 2 and sGAG, respectively (Fig. 2C), whereas triple 
weekly exposures for three weeks (9 total exposures) completely precluded an increase Col 2 and sGAG forma-
tion. The change in the amount of DNA across samples varied less than 0.2-fold, although reaching significances 
at 2 mT, indicating that cell proliferation was only modestly affected within our pellet culture system (Fig. 2C).
Effect of PEMF treatment to deposition of ECM. ECM deposition in response to PEMF-exposure was 
also analyzed using Safranin O staining for proteoglycan and immunohistochemical staining for type II collagen 
(Fig. 3). Stained images of day 21 samples showed an enhanced deposition of proteoglycan and type II collagen in 
samples exposed only once to 2 mT for 10 min as compared to control (0 mT). By contrast, MSC samples exposed 
for longer (60 min), to greater amplitude (3 mT) or repeatedly (3x, 9x) yielded comparable, or inferior, ECM 
deposition to control.
Ca2+ entry pathways implicated in transducing the effects of PEMFs over MSC differentia-
tion. To investigate whether PEMF-stimulated MSC chondrogenesis was depended on calcium influx, EGTA 
(2 mM) was co-administered to the culture medium during PEMF exposure and summarily replaced afterwards 
with age-matched chondrogenic control media. RNA analysis at day 7 showed that the inclusion of EGTA sig-
nificantly decreased the mRNA expression of Sox9, Col 2 and aggrecan in PEMF-treated samples (Fig. 4A), 
Figure 1. Effects of PEMF amplitude (A) and exposure duration (B) on MSC chondrogenesis. Real-time 
PCR analysis of cartilaginous markers expression after 7 days of differentiation was normalized to GAPDH 
and presented as fold-changes relative to levels in undifferentiated MSC. (C) Quantification of cartilaginous 
extracellular matrix macromolecules (Col 2 and sGAG) generated after 21 days of chondrogenic differentiation 
of MSC subjected to distinct PEMF parameters. All data shown are mean ± SD, n = 6 from 2 independent 
experiments. *Denotes significant increase, or decrease, compared to non-PEMF control. #Denotes significant 
decrease compared to 2 mT (A), or 10 min (B) PEMF exposure.
www.nature.com/scientificreports/
4ScieNtific REPORTs | 7: 9421  | DOI:10.1038/s41598-017-09892-w
indicating that PEMF-exposure stimulates calcium influx. Conversely, transiently supplementing the differen-
tiation medium with elevated extracellular Ca2+ (5 mM CaCl2) enhanced the mRNA expression of Sox9, Col 2 
and aggrecan in otherwise non-exposed samples, and moreover, accentuated chondrogenic gene expression in 
PEMF-treated samples. These results corroborate that calcium influx is part of the upstream signalling cascade 
recruited by PEMFs contributing to chondrogenic induction.
To reveal the Ca2+ influx pathway recruited by PEMFs, we pharmacologically dissected the contribution of 
candidate channels utilizing 2-APB (100 µM) or Ruthenium Red (RR, 10 µM) as TRPC or TRPV cation chan-
nel antagonists, respectively, or Nifedipine (1 µM), as a dihydropyridine-sensitive, L-type voltage-gated calcium 
channel (VGCC) antagonist. Calcium channel antagonists were included into the differentiation medium 10 min 
Figure 2. Dosage effects of PEMFs over MSC chondrogenesis. (A) MSCs were exposed once (1x), twice (2x) or 
thrice (3x) per week. (B) MSCs were subjected to either a single exposure on day 1 of chondrogenic induction 
(1x) or once per week for 3 weeks (3x). Real-time PCR analysis of cartilaginous markers expression at 7 (A) 
or 21 days (B) after the induction of differentiation was normalized to GAPDH and presented as fold-changes 
relative to level in undifferentiated MSCs. (C) Quantification of cartilaginous ECM macromolecules generated 
during chondrogenic differentiation of MSCs in response to distinct PEMF dosing as indicated. MSC pellets 
were subjected to either a single PEMF exposure given on day 1 of chondrogenic induction (1x) once per week 
for 3 weeks (3x), or thrice weekly for 3 weeks (9x). Data represents the mean ± SD, n = 6 from 2 independent 
experiments. *Denotes significant increase compare to non-PEMF (0 mT) control. #Denotes significant decrease 
compared to single PEMF (1x) exposure.
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before exposure to PEMFs and removed immediately afterwards with age-matched control chondrogenic media. 
Both 2-APB and Ruthenium Red completely inhibited the PEMF-triggered up-regulation of chondrogenic 
genes, whereas Nifedipine had no significant inhibitory effect (Fig. 4B). Chondrogenic inhibition by 2-APB and 
Ruthenium Red was also observed in non-exposed samples, indicating that TRPC- and TRPV-mediated calcium 
entry are similarly involved in constitutive chondrogenesis upon induction. By contrast, VGCC-mediated Ca2+ 
entry does not appear to play a predominant role in the early induction of chondrogenesis.
We next investigated the expression profiles of TRP channels (TRPC1, TRPC6, TRPV1, TRPV4, TRPV6) 
previously implicated in chondrogenesis and correlated these to our PEMF-induced chondrogenic responses. 
Amongst the panel of candidate TRP channels, the expression of TRPC1 and TRPV4 most closely correlated with 
our delineated magnetic efficacy window governing chondrogenesis with reference to PEMF amplitude, duration 
Figure 3. Histological analysis of pellets exposed to PEMFs of distinct amplitude, duration and dosage. Pellets 
were harvested at day 21, sectioned and subjected to Safranin O or type II collagen immunohistochemistry 
staining. Images presented were represenation of n = 3, taken at 100× magnification.
Figure 4. Investigation of calcium entry pathways implicated in the PEMF-effect. (A) Involvement of Ca2+ 
influx in mediating the effects of PEMF-induced MSC chondrogenic differentiation. MSCs were exposed 
for 10 min at 2 mT alone (control, white bars), or in the presence of 2 mM EGTA (dark grey bars) or 5 mM 
CaCl2 (hatched bars) transiently added to the culture media. EGTA and CaCl2 were included to the bathing 
media 10 min before exposure and replaced with age-matched media control cultures 10 min after exposure. 
(B) Involvement of candidate calcium channels in mediating the effect of PEMs over MSC chondrogenic 
differentiation. Control MSC chondrogenic differentiation medium (white bars) was supplemented with 
Nifedipine (1 µM, light grey bars), Ruthenium Red (RR, 10 µM, black bars), or 2-APB (100 µM, dark grey bars) 
10 min before exposure and replaced with age-matched media control cultures 10 min after exposure. Real-
time PCR analysis was performed on day 7 of differentiation. Data represent the means ± SD, n = 6 from 2 
independent experiments. *Denotes significant increase, or decrease, compared to non-PEMF (0 mT) control. 
#Denotes significant decrease relativeto 2 mT PEMF treatment.
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and dosage (Fig. 5 and Suppl. Figures 1 and 2). These results corroborate an involvement of TRPC1 and TRPV4 
in the PEMF-induced enhancement of chondrogenic differentiation of MSC we observed.
Effect of recurring calcium influx on MSCchondrogenesis. We next investigated whether calcium 
entry, particularly that via TRPchannels underlies the inhibitory effect observed with repeated PEMF exposures. 
MSCs were exposed once, twice or thrice to 2 mT PEMFs for 10 min or, alternatively, exposed for 10 min to 
aged-matched control differentiation media containing elevated extracellular calcium (5 mM CaCl2) in lieu of 
PEMF exposure. RNA analysis at day 7 showed that MSCs treated once with PEMFs, or transiently administered 
elevated calcium, on day 1 exhibited enhanced chondrogenesis to comparable levels. By contrast, subsequent 
exposures to elevated calcium, on days 2 and 4 suppressed chondrogenesis mirrored the effect of multiple expo-
sures to PEMFs (Fig. 6A and Suppl. Fig. 3A).
Analogously, precluding calcium entry (with EGTA) also exhibited dichotomous effects if applied during 
the first versus the second or third exposition to PEMFs, although in opposite direction to that observed with 
calcium administration or PEMFs. Whereas EGTA added during the initial exposure to PEMFs (1x) prevented 
PEMF-induced chondrogenesis, EGTA applied during the second or third exposure partially counteracted the 
Figure 5. Expression profiles of TRPC1 and TRPV4 in response to determined PEMF efficacy window 
regulating MSC chondrogenesis. Real-time PCR analysis of TRPC1 and V4 exposed to different (A) intensities, 
(B) durations, and (C) dosages of PEMFs. Data represent the means ± SD, n = 6 from 2 independent 
experiments. *Denotes significant increase, or decrease, compared to non-PEMF (0 mT) control. #Denotes 
significant decrease relative to 2 mT (A), 10 min (B), or single (1x, C) PEMF treatment.
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inhibition of differentiation exerted by serial PEMF exposure (Fig. 6B and Suppl. Fig. 3B). Notably, impeding cal-
cium entry with transient application of EGTA during both the second and third PEMF exposure was capable of 
almost completely reversing the inhibition of chondrogenesis observed with repeated PEMF exposures, suggest-
ing that PEMFs are activating disparately functioning calcium mechanisms at early (day 1) and later stages (>day 
2) of chondrogenic-induction that confer opposite effects over chondrogenesis. In contrast to the beneficial effect 
of calcium influx induced by PEMF at the initial stage of chondrogenesis, subsequent induction of calcium influx 
by repeated pulsing at later stages of chondrogenesis was suppressive of MSC chondrogenesis. The contribution of 
TRPC- and TRPV-mediated calcium entry to the chondrogenic-inhibition observed with repeated PEMF expo-
sures was investigated by co-administering 2-APB (100 µM) or Ruthenium Red (RR, 10 µM), respectively, during 
PEMF exposure. As observed with transient EGTA application, antagonism of TRPC1/V4-mediated calcium 
entry during the first exposition to PEMFs was strongly inhibitory of PEMF-induced chondrogenesis, where-
asTRPC1/V4 antagonism during subsequent PEMF expositions was somewhat less protective than EGTA over 
differentiation (Fig. 6B), implicating other yet to be determined calcium pathways in the later calcium-dependent 
inhibitory phase of chondrogenic progression. Notably, Ruthenium Red (TRPV4 antagonist) was capable of 
reverting the inhibition of differentiation and expression of TRPC1 expression in response to repeated PEMFing, 
whereas 2-APB (TRPC antagonist) was unable to revert the inhibition of differentiation and TRPV4 expression 
in response to repeated PEMFing, suggesting that TRPV4-mediated calcium entry antagonizes TRPC1 expres-
sion leading up to differentiation suppression. The dichotomous effects of precluding calcium entry by EGTA, 
Ruthenium Red or 2-APB when applied during the first, or the second and third, exposition to PEMFs was 
corroborated at the protein level. Preventing calcium entry during the initial exposure to PEMFs (1x) prevented 
Figure 6. (A) MSC chondrogenic differentiation in response to multiple exposures to PEMFs or exogenously 
elevated calcium. MSCs were subjected to either PEMF stimulation alone (white bars) or with transient 
supplementation of CaCl2 alone (5 mM; hatched bars), once (1x), twice (2x) or thrice (3x) in a week. Dotted 
lines refers to expression level of non-treated controls. Real-time PCR analysis was performed on day 7 of 
chondrogenic differentiation. *Denotes significant increase relative to non-PEMF (0 mT) control. # and + 
denote significant differences relative to respective single (1x) exposure (white and hatched bars, respectively). 
P = PEMF treatment, Ca = CaCl2 supplementation. (B) MSC chondrogenic differentiation in response to 
multiple exposures to PEMFs alone (white bars) or in combination with calcium chelator (EGTA) or TRP 
channel antagonists. EGTA (2 mM; dark grey bars; “E”), Ruthenium Red (10 µM; RR, black bars; “R”) or 2-APB 
(100 µM; light grey bars; “C”) was added to the MSC differentiation medium during PEMF expoure applied 
once (1x), twice (2) or thrice (3x) per week. EGTA, RR and 2-APB were included 10 min before exposure 
and replaced with media harvested from age-matched chondrogenic control cultures 10 min after exposure. 
*Denotes significant increase compare to non-PEMF (0 mT) control. #Denotes significant decrease compared to 
single PEMF exposure (1x). +Denotes significant difference compared to respective PEMF control (white bar). 
P = PEMF treatment, E = EGTA, R = Ruthenium Red (RR), C = 2-APB. Data shown are means ± SD, n = 6 from 
2 independent experiments.
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PEMF-induced cartilaginous Col 2 and sGAG formation, while blocking calcium entry at later exposures coun-
teracted the inhibition of differentiation exerted by serial PEMF exposure (Fig. 7). Voltage-gated L-type calcium 
channels, on the other hand, do not appear to be strongly implicated in the response as the expression of its subu-
nits (CACNA1C and CACNA2D1) was not perturbed by PEMF or calcium treatment (Suppl. Fig. 3).
Discussion
Pulsed electromagnetic fields (PEMFs) have been demonstrated to be influential in numerous biological functions 
including progenitor cell fate determination and differentiation. PEMF-based therapies have been previously 
shown to enhance chondrocyte and cartilage explant anabolism while also limiting the catabolic consequences of 
inflammatory cytokines29–31, 33–35, 40. PEMF exposure has been also reported to enhance the chondrogenic induc-
tion of stem cells34–37, 45. Nevertheless, inconsistent and conflicting results plague the scientific literature in this 
area of study, with PEMF exposures typically being applied on the order of hours per day for several days or 
weeks at a time. Here we report a high-efficacy of unprecedentedly brief (10 min applied once) PEMF expo-
sure at inducing MSC chondrogenesis. We consistently detected increases in Sox9, Col 2 and aggrecan mRNA 
(>2-folds) in response to lone exposure to 2 mT PEMFs applied at the commencement of induction for only 
10 min (Fig. 1). These increments in mRNA later translated into increased chondrogenic ECM protein forma-
tion (>2-fold) after 21 days of differentiation. By contrast, stimulation with greater amplitudes (>3 mT), longer 
exposures (>20 min) or more frequently (>2x/week) rendered no additional benefit, or was even less effective 
at promoting chondrogenesis at both the gene and protein levels. Although higher PEMF amplitudes and longer 
duration exposures were capable of augmenting aggrecan mRNA expression and macromolecular sGAG forma-
tion, the levels achieved were no better than those from samples treated only once with 2 mT PEMFs for 10 min. 
Col 2 expression was especially susceptible to overstimulation, being negatively impacted by exposures >2 mT or 
longer than 10 minutes. To the best of our knowledge, all published EMF studies examining chondrogenesis have 
employed exposure durations between 30 min to 8 h28, 35, 37, 38. For instance, Mayer-Wagner et al.38 using PEMF of 
15 Hz, 5 mT, exposed MSCs undergoing chondrogenesis for 45 min every 8 h for a total of 21 days and observed 
less than a 2-fold increase in type II collagen expression, with no detected effect on Sox9 or aggrecan expression. 
Wang et al.37 using 1, 2, and 5 mT PEMFs at the frequency of 75 Hz exposed MSCs for 3 h per day for 4 weeks 
and instead observed a loss of cartilaginous phenotype associated with increased cartilage-specific extracellular 
matrix degradation in the later stage of chondrogenic differentiation.
Given that most conventional PEMF exposure paradigms employ a multiple exposure strategy and have 
reported positive chondrogenic outcome35, we sought to determine the minimal number of exposures necessary 
to promote chondrogenesis (Fig. 2). We found that exposing MSCs once at the commencement of chondrogenic 
differentiation (1x) was necessary and sufficient to induce chondrogenic gene expression (Fig. 2A), which was 
sustainable for up to 21 days post chondrogenic-induction (Fig. 2B). The superior effect of a single pulse was 
also confirmed at the level of sGAG and Col 2 protein deposition (Figs 2C and 3). Indeed, in response to 3 
Figure 7. Quantification of cartilaginous ECM macromolecules generated by chondrogenically differentiated 
MSC in response to single or three weekly PEMF exposures alone (white bars) or in combination with calcium 
chelator (EGTA) or TRP channel antagonists as indicated. EGTA (2 mM; dark grey bars; “E”), Ruthenium Red 
(10 µM; RR, black bars; “R”) and 2-APB (100 µM; light grey bars; “C”) were included once during single PEMF 
exposures, or twice during the second and third PEMF exposure. EGTA, RR and 2-APB were added 10 min 
before exposure and replaced with media harvested from age-matched chondrogenic control cultures 10 min 
after exposure. *Denotes significant increase compare to non-PEMF (0 mT) control. #Denotes significant 
decrease compared to single PEMF exposure (1x). +Denotes significant difference compared to respective 
PEMF control (white bar). P = PEMF treatment, E = EGTA, R = Ruthenium Red (RR), C = 2-APB. Data 
represent means ± SD, n = 3.
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exposures per week (10 min pulsing) for 3 consecutive weeks (9x treatments), ECM deposition was unchanged, 
or even inhibited, relative to unexposed samples. Ours is likely the first report to demonstrate an effectiveness 
of lone, 10 min, low amplitude PEMF exposures over MSC chondrogenesis, while concomitantly demonstrating 
the counter productivity of prolonged or repeated exposures. The possibility that prolonged or repeated PEMF 
exposures were merely cytotoxic, rather than truly inhibitory to chondrogenesis, was ruled out by our finding 
that total DNA content across all treatments was largely unchanged, despite lower Col 2 yield. In addition, the 
amount of sGAG was either unchanged or higher than that in control non-pulsed samples, further indicating 
that prolonged/repeated PEMF exposure did not adversely influence cell viability. Finally, the PEMF paradigm 
demonstrated here to best promote chondrogenesis (2 mT applied once for 10 min) did not alter the expression of 
osteogenic genes, Runx2 and ALP (Suppl. Fig. 4). Provocatively, osteogenic markers did increase following 20 min 
exposure to 2 mT PEMFs, thereby substantiating our assertion that reduced chondrogenic expression is not a 
reflection of cell death, but likely deferred chondrogenesis towards osteogenesis. Our demonstration of the high 
efficacy of brief and early PEMF exposure might thus help explain the existing inconsistencies and the relatively 
weaker responses previously reported28, 30, 32, 34–38.
Chondrogenesis is known to be modulated by calcium signaling cascades of specific temporal sensitivity24, 46. 
The dependence of chondrogenesis on extracellular Ca2+ was first alluded to with the demonstration that elevated 
extracellular Ca2+ promoted chondrogenic differentiation in chick limb bud-derived cultures47, 48. Moreover, 
Sox9, the master transcription factor of chondrogenesis, is subject to Ca2+-calmodulin regulation49. Elevation 
in cytoplasmic calcium downstream of calcium influx has been demonstrated in response to electric field (EF) 
or EMF stimulation during MSC-derived osteogenesis or chondrogenesis27, 50, 51. We show that MSC chondro-
genesis depends on the presence of extracellular Ca2+, whereby a transient (10 min) elevation of extracellular 
Ca2+ or brief (10 min) exposure to PEMFs (Figs 4A and 6A) enhanced MSC chondrogenic differentiation in an 
additive manner. Previous studies have also revealed that chondrogenesis is positively responsive to intracellular 
Ca2+ within a tightly controlled concentration window24, 46. A 1.25-fold increase in cytosolic Ca2+ concentration 
was shown to promote differentiation, whereas a moderately greater increase (1.5-fold) negatively influenced 
in vitro chondrogenesis48. It is thus feasible that high amplitude or prolonged PEMF exposures elevate cyto-
plasmic calcium levels beyond the beneficial threshold for MSC chondrogenic differentiation46. It is also well 
documented that the spatial and temporal patterns of intracellular free Ca2+ concentration play important roles 
in the regulation of various cellular processes, governed not only by absolute Ca2+ level, but also by periodic 
oscillatory changes of cytosolic Ca2+ concentration48, 52. MSCs undergoing chondrogenesis increase their fre-
quency of Ca2+oscillations (waves) in the early stages of differentiation48, coinciding with the initial period of 
cellular condensation during the first 2–4 days10. Conversely, sustained elevations of extracellular calcium inhibit 
chondrogenesis48, demonstrating a temporal requirement for calcium. Here we show that transient pulsing with 
elevated calcium recapitulates the temporal characteristic of the inhibitory actions of repeated PEMF exposures 
(Fig. 6A). Moreover, preventing calcium entry (with EGTA) during repeated PEMF exposure precludes the inhi-
bition (Figs 6B and 7), defining a developmental change in calcium-sensitivity following calcium-dependent ini-
tiation of chondrogenesis. In this respect, single brief exposition to PEMFs defined by a specified electromagnetic 
window applied during the early stages of MSC chondrogenesis may be sufficient to provide the correct catalytic 
rise in intracellular Ca2+ to optimally promote the initiation of chondrogenesis. Conversely, higher exposure 
intensities or multiple exposures could result in excessive or sustained calcium influx that may instead disrupts or 
interrupts MSC-induced chondrogenesis, respectively.
Ca2+ influx via membrane-associated cation channels is a key event in initiating chondrogenesis, that can be 
potentially mediated by either TRP channels and/or voltage-gated calcium channels (VGCC)24, 44, 46. The transient 
receptor potential (TRP) channels are a diverse and widely distributed family of cation channel broadly impli-
cated in cellular mechanotransduction23, 53–57. The TRPC and TRPV subfamilies have been broadly implicated in 
calcium homeostasis, ascribed mechanically-mediated gating44, 57–61, as well as implicated in the developmental 
programs of diverse mechanosensitive tissues62, 63. Previous studies have shown that blocking TRPV4 during 
the initial stages of induction inhibited chondrogenesis60, 64. TRPV4-mediated Ca2+ signaling is also a positive 
regulator of Sox9 and as such, has been shown to promote chondrogenesis65 and in transducing the mechanical 
signals that support cartilage extracellular matrix maintenance and joint health44, 59. TRPC1 is expressed during 
early chondrocyte expansion66, as well as being involved in the proliferation of mesenchymal stem cells67. We 
detected time, intensity, and PEMF dosage-dependent up-regulations of both TRPV4 and TRPC1 that closely 
correlated with the PEMF-induced expression pattern of chondrogenic markers (Fig. 5). Blocking TRPC1 and 
TRPV4 channels with 2-APB68 and Ruthenium Red64, respectively, in the early stage of differentiation effectively 
inhibited chondrogenesis, implicating these TRP channels in the initiation of chondrogenesis, and indicating that 
PEMFs recruit the activity of these channels to enhance chondrogenesis. Notably, blocking calcium-permeation 
through TRPV4 channels reverses the inhibition on chondrogenic differentiation and TRPC1 expression during 
repeated PEMF exposure, whereas blocking TRPC1 channels was unable to revert the inhibition on differen-
tiation and expression of TRPV4 in response to repeated PEMF exposure, suggesting that TRPV4-mediated 
calcium entry antagonizes TRPC1 expression and is an essential step in initiating differentiation (Figs 6B and 7). 
TRPV4-mediated calcium entry may thus increase after the induction of differentiation (>2 days) serving to cur-
tail TRPC1 expression and thereby promote differentiation by inhibiting TRPC1-medited proliferation (Suppl. 
Fig. 2).
An involvement of voltage-gated calcium channels was more difficult to establish. A predominant role 
for L-type VGCCs (CACNA1, CACNA2D1) in transducing PEMF’s effects was not supported given that a 
chondrogenically-effective dose of, Nifedipine, a L-type VGCC antagonist53–55, had no significant effect on the 
PEMF-induced upregulation of MSC chondrogenesis (Fig. 4B). Moreover, the expression level of the L-type chan-
nel was not correlated with changes in calcium (Suppl. Fig. 3). Ca2+ influx via the low-threshold T-type VGCC 
had been previously implicated in tracheal chondrogenesis56. The expression of T-type VGCC (CACNA1H) was 
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induced by lone early exposure to PEMFs or transient calcium administration, and was suppressed by repeated 
exposures to PEMF or extracellular calcium, mirroring the expression pattern of chondrogenic markers under 
identical conditions (Suppl. Fig. 3A). The induction of the T-type calcium channel in response to PEMF/calcium 
exposure more likely reflects chondrogenic differentiation, rather than a fully determinant role in PEMF-induced 
chondrogenesis, as its expression was in the majority of conditions unchanged (relative to control) by removal of 
extracellular calcium during PEMF exposure (Suppl. Fig. 3B). Our strongest data support the interpretation that 
TRPC1 and TRPV4 play a more predominant role, although not necessarily exclusive, in transducing the chon-
drogenic effects of PEMFs. Further work will require to fully disentangle the intricasy of calcium homeostasis 
during the chondrogenic developmental process.
In summary, we have provided comprehensive characterization of the effects of PEMFs over MSC chondro-
genic differentiation. MSCs undergoing chondrogenic induction are preferentially responsive to a well-defined 
window of PEMF stimulation of particular amplitude (2 mT), duration (10 min) and dosage (once on day 1 induc-
tion). By contrast, treatment with higher amplitude PEMFs, longer exposure durations or repeated expositions, 
as are more common in the field, are generally counterproductive, helping explain the lack of resolution in the 
field. Our results indicate that PEMFs mediate their effect by activating calcium influx through mechanosensitive 
calcium TRP channels. The unprecedented efficacy of our low amplitude, exceptionally brief and non-invasive 
PEMF-exposure protocol over MSC chondrogenesis has broad clinical and practical implications for the ultimate 
translation of related PEMF-based therapeutic strategies for stem cell-based cartilage regeneration.
Methods
Human bone marrow MSCs culture and chondrogenic differentiation. Primary human mesen-
chymal stem cells (MSCs) were purchased from RoosterBio Inc. (Frederick, MD), supplied at passage 3. The 
MSCs was further expanded in MSC High Performance Media (RoosterBio Inc.) at 37 °C in 5% CO2 atmosphere. 
The expanded MSCs were used at passage 5–6. Chondrogenic differentiation of MSCs was induced through 3D 
pellet culture as previously described16, 69. Briefly, 2.5 × 105 cells were centrifuged to form pellets and cultured in a 
chondrogenic differentiation medium containing high glucose DMEM supplemented with 4 mM proline, 50 µg/
mL ascorbic acid, 1% ITS-Premix (Becton-Dickinson, San Jose, CA), 1 mM sodium pyruvate, and 10−7 M dexa-
methasone (Sigma-Aldrich, St Louis, MO), in the absence of antibiotics, for up to 7 or 21 days in the presence of 
10 ng/mL of transforming growth factor-β3 (TGFβ3; R&D Systems, Minneapolis, MN). To investigate an involve-
ment of calcium influx or of calcium channels in transmitting the effects of PEMFs, cells were pre-incubated in 
chondrogenic media supplemented with elevated calcium, EGTA or particular calcium channel antagonist for 
10 minutes prior to pulsing. Ten minutes after exposure to PEMFs the supplemented chondrogenic media was 
replaced with age-matched chondrogenic media (0 mT) cultures. To attenuate extracellular calcium influx, 2 mM 
ethylene-bis(oxyethylenenitrilo) tetraacetic acid (EGTA; Sigma) was added to the bathing media as noted. To pro-
mote extracellular Ca2+ influx the bathing media was supplemented with 5 mM CaCl2 (Sigma). To block calcium 
permeation through dihydropyridine-sensitive, L-type voltage-gated calcium channel (VGCC), Nifedipine (1 µM, 
Sigma) was added to the bathing media. 2-aminoethoxydiphenyl borate (2-APB, 100 µM, Sigma) and Ruthenium 
Red (10 µM, Merck Millipore) were administered as indicated to block calcium entry via TRPC and TRPV chan-
nels, respectively. Aminoglycoside antibiotics such as streptomycin were excluded in all MSC expansion and 
chondrogenic differentiation media to avoid interference with mechanosensitive ion channels70.
PEMF Exposure system. The ELF-PEMF (extremely low frequency – pulsed magnetic field) delivery sys-
tem has been described previously43. For the purposes of this study a barrage of magnetic pulses of 6 ms duration 
was applied at a repetition rate of 15 Hz and at flux densities between 1–4 mT. Each 6 ms burst consisted of a 
series of 20 consecutive asymmetric pulses of 150 µs on and off duration with an approximate rise time of 17 T/s. 
The background magnetic flux density measured in the chamber was below 1 µT between 0 Hz to 5 kHz. The coil 
size, position and individual number of windings were numerically optimized by a CST low frequency solver 
for low field non-uniformity over a wide frequency range taking into consideration the shielding capacity of the 
µ-metallic chassis. The measured field non-uniformity did not exceed 4% within the uniform exposure region of 
the coils.
PEMF treatment. To investigate the optimum dosage of PEMF, MSCs in a 3D pellet culture were exposed to 
PEMFs of different exposure durations, dosage and the magnetic flux amplitude. MSCs were subjected to PEMFs 
of 1–4 mT amplitude with exposure times ranging between 5 to 60 min on the day of chondrogenic induction, 
applied once or multiple times as indicated in the respective figure legend. Cell pellets to be treated once with 
PEMFs (1x) were exposed on first day of chondrogenic induction. Two scenarios of multiple exposures were 
administrated (Fig. 2). Firstly, multiple exposures were administrated during the course of a week; double expo-
sures (2x) were applied on days 1 and 2; triple exposures (3x) on days 1, 2 and 4. Alternatively, multiple exposures 
were applied on a once a week basis, for up to three week. Non-exposed (control) cells were placed within the 
PEMF device without current flux to produce a magnetic field to ensure that all cells were subject to the same 
climatic and mechanical conditions.
Real time PCR analysis. Chondrogenic cell pellets were digested in 0.25% Type II collagenase (Gibco, 
Life Technologies) followed by centrifugation. Total RNA was extracted using the RNeasy® Mini Kit (Qiagen, 
Germany). Reverse transcription was performed with 100 ng total RNA using iScript™ cDNA synthesis kit 
(Bio-Rad, USA). Real-time PCR was conducted using the SYBR®green assay on ABI 7500 Real-Time PCR System 
(Applied Biosystems, Life Technologies, USA). Real-time PCR program was set at 95 °C for 10 min, followed by 
40 cycles of amplifications, consisting of a 15 s denaturation at 95 °C and a 1 min extension step at 60 °C. Primer 
sequences used in this study were according to previous publication16 and presented as Supplementary Table 1. 
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The level of expression of the target gene, normalized to GAPDH, was then calculated using the 2−ΔΔCt formula 
with reference to the undifferentiated MSC. Results were averaged from triplicate samples of two independent 
experiments.
ECM and DNA quantification. Samples harvested were digested with 10 mg/mL of pepsin in 0.05 M acetic 
acid at 4 °C, followed by digestion with elastase (1 mg/mL). A Blyscan sulfated glycosaminoglycan (sGAG) assay 
kit (Biocolor Ltd., Newtownabbey, Ireland) was used to quantify sGAG deposition according to manufactur-
er’s protocol. Absorbance was measured at 656 nm and sGAG concentration was extrapolated from a stand-
ard curve generated using a sGAG standard. Type II Collagen (Col 2) content was measured using a captured 
enzyme-linked immunosorbent assay (Chondrex, Redmond, WA). Absorbance at 490 nm was measured and 
the concentration of Col 2 was extrapolated from a standard curve generated using a Col 2 standard. Values for 
sGAG and Col 2 content obtained were normalized to the total DNA content of respective samples, measured 
using Picogreen dsDNA assay (Molecular Probes, OR, USA). Quadruplicates of each group were analyzed from 
two independent experiments.
Histological and immunohistochemical evaluation. Samples were fixed in formalin, dehydrated, par-
affin embedded, and cut into sections of 5 µm. For Safranin-O staining, the sections were incubated in hema-
toxylin (Sigma-Aldrich), washed and stained with fast green (Sigma-Aldrich), before staining with Safranin-O 
solution (AcrosOrganics). For immunohistochemistry, ultra-vision detection kit (Thermo scientific) was used. 
Endogenous peroxidase in the sections was first blocked with hydrogen peroxide before pepsin treatment for 
20 min. Samples were treated with monoclonal antibodies of collagen type II (Clone 6B3; Chemicon Inc.) fol-
lowed by incubation with biotinylated goat anti-mouse (Lab Vision Corporation). A mouse IgG isotype (Zymed 
Laboratories Inc.) was used as control for immunohistochemistry studies.
Statistical analysis. All experiments were performed in biological replicates (n = 3 or 4) and results 
reported as mean ± standard deviation (SD). Statistical analysis was carried out by Students t-test for comparison 
between two groups using the Microsoft Excel software. The level of significance was set at p < 0.05. All quantita-
tive data reported here were averaged from at least two independent experiments.
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